 |
 |
Interesting comments from Trevor regarding Jonathan's 'last sentence'. We have for some time been battling with a local consultant regarding his almost routine requests for alpha-1 antitrypsin, caeruloplasmin and copper assays in patients with 'Abnormal Liver function tests'. The abnormalities are usually fairly minor increases in liver enzymes. The aforementioned tests are sent to other laboratories by us and therefore are relatively expensive. His argument is that by doing all these tests at one hit, he is reducing the number of clinic visits required by his patients, i.e. one clinic visit saved is a lot more cost-effective for the Trust as a whole, compared to the relatively minor expense to the Lab. All very well, but none of the savings seem to come the laboratory's way! Brian Martin ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/